107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details
臨床試験数 : 447 / 薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146
Showing 1 to 4 of 4 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EUCTR2004-004153-25-GB (EUCTR) | 10/12/2004 | 17/02/2005 | Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. - rhGH in JIA Effect of recombinant growth hormoneon growth and chondrocyte dynamics in children with juvenile idi ... | Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. - rhGH in JIA Effect of recombinant growth hormoneon growth and chondrocyte dynamics in children with juvenile idi ... | Growth retardation secondary to juvenile idiopathic arthritis | Trade Name: Norditropin SimpleXx 5mg/1.5ml Product Name: Norditropin SimpleXx INN or Proposed INN: Somatropin Other descriptive name: Growth Hormone Trade Name: Norditropin SimpleXx5mg/1.5ml Product Name: Norditropin SimpleXx INN or Proposed INN: Soma ... | Royal Hospital For Sick Children, Yorkhill Division | NULL | Not Recruiting | Female: yes Male: yes | United Kingdom | ||||
2 | NCT00420251 (ClinicalTrials.gov) | March 1996 | 9/1/2007 | Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis | Recombinant Human Growth Hormone Treatment in Juvenile Idiopathic Arthritis: Controlled Study on the Effect on Growth and Bone Development Recombinant Human Growth HormoneTreatment in Juvenile Idiopathic Arthritis: Controlled Study on the ... | Juvenile Idiopathic Arthritis;Still Disease, Juvenile-Onset | Drug: Genotropin | Ludwig-Maximilians - University of Munich | Pfizer | Completed | 4 Years | 14 Years | Both | 50 | Phase 3 | Germany |
3 | EUCTR2014-004105-32-Outside-EU/EEA (EUCTR) | 01/04/2015 | Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With Chronic Juvenile Arthritis (CJA) Treated by Corticosteroid Therapy Prevention of Growth Retardation by Early Treatment With Growth Hormone(GH) in Children With Chronic ... | Prevention of Retarded Growth by Early Treatment With Recombinant Human Growth Factor (Genotonorm) in Children With Systemic Forms of Chronic Juvenile Arthritis Receiving Long-Term Corticosteroid Therapy. Extension of the Study Beyond Three Years. Prevention of Retarded Growth by Early Treatment With Recombinant Human Growth Factor (Genotonorm) i ... | Juvenile idiopathic arthritis (JIA);Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] | Product Name: Genotropin INN or Proposed INN: Somatropin Other descriptive name: SOMATROPIN | Pfizer Inc | NULL | NA | Female: yes Male: yes | 21 | France | ||||
4 | EUCTR2014-004104-30-Outside-EU/EEA (EUCTR) | 01/04/2015 | Treatment With Recombinant Human Growth Hormone (Genotonorm) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and Safety Treatment With Recombinant Human Growth Hormone(Genotonorm) in Children With Short Stature Secondary ... | Treatment With Recombinant Human Growth Hormone (Genotonorm) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and Safety Treatment With Recombinant Human Growth Hormone(Genotonorm) in Children With Short Stature Secondary ... | Juvenile idiopathic arthritis (JIA) and nephrotic syndrome (NeS);Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] Juvenile idiopathic arthritis (JIA) and nephrotic syndrome (NeS);Therapeutic area: Diseases [C] - Mu ... | Product Name: Genotropin INN or Proposed INN: Somatropin Other descriptive name: SOMATROPIN | Pharmacia & Upjohn S.A. | NULL | NA | Female: yes Male: yes | 30 | France |